5GP-34192-13823
3 vaccinations
3 coded responses
21 check-ins
3 free-text entries
2 call cases
- Sex
- —
- Age at first dose
- 31-35
- ZIP prefix
- 189 / PA
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Survey response — day 0, dose 1MedDRA: Dysgeusia — Feeling: GoodFree text: Metallic tasteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2020-12-28
- 2020-12-29
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Survey response — days 1–6 daily, dose 2MedDRA: Dysgeusia — Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Metallic taste in mouthMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
- 2021-01-15
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-10-04
Dose 3 — Pfizer-BioNTech
-
2022-01-12
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnantMedDRA releases: 2024-11 · check-in free text available
- 2022-10-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-13 | priority 2/3 | |
| 2021-01-14 | priority 2/3 |
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Metallic taste
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Metallic taste in mouth
Release 10 — 12 months, dose 2
Symptoms: Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SRO | Dysgeusia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release